Rajesh Kumar Grover

Summary

Rajesh Kumar Grover is an Indian oncologist and former director and chief executive officer of Delhi State Cancer Institute, New Delhi.[1][2] The Government of India honoured him, in 2014, with the award of Padma Shri, the fourth highest civilian award, for his contributions to the field of medicine.[3][4]

Rajesh Kumar Grover
Born
India
OccupationOncologist
AwardsPadma Shri

Dr Grover has over 50 scientific papers to his credit and has attended over 100 conferences and workshops in India and abroad. [5][6][7][8] Research Gate has published ten of his articles in their online repository.[9]

References edit

  1. ^ "Delhi State Cancer Institute". Delhi State Cancer Institute. 2014. Retrieved November 7, 2014.
  2. ^ "India Medical Times". India Medical Times. 2014. Retrieved November 7, 2014.
  3. ^ "Padma 2014". Press Information Bureau, Government of India. 25 January 2014. Retrieved October 28, 2014.
  4. ^ "Drug Today". Drug Today. 2014. Retrieved November 7, 2014.
  5. ^ "Delhi State Cancer Institute". Delhi State Cancer Institute. 2014. Retrieved November 7, 2014. [verification needed]
  6. ^ "India Medical Times". India Medical Times. 2014. Retrieved November 7, 2014. [verification needed]
  7. ^ "Padma 2014". Press Information Bureau, Government of India. 25 January 2014. Retrieved October 28, 2014. [verification needed]
  8. ^ "Drug Today". Drug Today. 2014. Retrieved November 7, 2014. [verification needed]
  9. ^ "CTRI". CTRI. 2011. Retrieved November 7, 2014. [verification needed]

Further reading edit

  • Gargi Tikku; Dhruv Jain; Rajesh K Grover (October 2014). "Malignant proliferating trichilemmal tumor of the scalp masquerading as squamous cell carcinoma: A need for common awareness". Indian Journal of Pathology and Microbiology. 57 (4): 646–647. doi:10.4103/0377-4929.142705. PMID 25308032.
  • R. K. Grover; Dhruv Jain (November 2014). "Re: Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? – Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) Database". European Urology. 66 (5): 967–968. doi:10.1016/j.eururo.2014.08.031. PMID 25763446.

External links edit